Search
-
Ipsos Update – November 2025
Healthcare, Indulgence, Risk … Ipsos Update explores the latest research and thinking on key topics from Ipsos teams around the world.
-
Know the New America & Beyond: October 2025
A monthly dispatch of Ipsos’ best insights on the U.S., tailored for the world.
-
Low awareness of GLP-1s globally, but high in the most advanced economies
Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.
-
Ipsos Rx Insight Store: Your On-Demand Hub for Healthcare Market Intelligence
Built on the foundation of Ipsos’ gold-standard Global Healthcare Monitors, the Ipsos Rx Insight Store offers standardised reports and dashboards that empower biopharma companies to make rapid, informed decisions for brand success.
-
Unlock Strategic Advantage with Ipsos' New Insights Agent
Ipsos launches Insights Agent, its agentic AI solution to unlock faster, smarter decision-making by connecting your information and transforming it into impact.
-
Transforming Research Through Synthetic Data
Synthetic data, powered by AI, is poised to transform the market research industry. The question isn’t if, but when and how.
-
Ipsos strengthens its expertise in Germany with the acquisition of InMoment's Healthcare division
Acquisition announcement from Ipsos.
-
Ipsos launches GLP-1 PersonaBot, designed to support companies’ understanding of the consumer obesity treatment market
Ipsos’ latest AI-powered innovation offers unparalleled insights into the fast-moving consumer obesity treatment market – while reinforcing Ipsos’ position at the forefront of AI applications in market research.
-
Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
Our evolutionary tale began 6 million years ago, when humans were programmed to hoard calories in a world of scarcity. Today, that ancient wiring has become our greatest health risk.